Kathryn J. Collier - Director at Regulus Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
RGLS on Nasdaq
All Insider Reports
All Insider Reports

Kathryn J. Collier - trading volume in the past year for Regulus Therapeutics Inc.

Holdings reported by Kathryn J. Collier for Regulus Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 6.74K $12.3K $1.82 Jul 25, 2024 Direct
Stock Option (Right to Buy) 60K May 20, 2024 Direct Common Stock

Transactions reported by Kathryn J. Collier for Regulus Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.